Skip to content

SPP closes at 5pm AWST Wed 25th Nov 2026  Learn more    

Australian patent for PromarkerEndo

 

Proteomics International secures Australian patent notice of acceptance for endometriosis innovative diagnostic test

  • IP Australia has provided a notice of acceptance for a patent protecting the PromarkerEndoproprietary blood test for the diagnosis of endometriosis

  • Major milestone with patent granted in PIQs local healthcare market

  • The patent supports commercialisation efforts and underpins the commercialisation pathway,enabling future partnerships and licensing opportunities.

  • Published clinical data has demonstrated the patented blood test has high accuracy fordiagnosing endometriosis, including in the early stages of the disease

  • Patent protection for the PromarkerEndo technology has now advanced in major jurisdictionsincluding Japan, the United States and Australia

  • Global need - endometriosis affects one in nine women and currently diagnosis typically takes anaverage of 7 years

 

View ASX Announcement: here